MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood-2009-03-209221

Медицинская библиотека · Blood · 2009

ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency.

Sauer Aisha V, Mrak Emanuela, Hernandez Raisa Jofra, Zacchi Elena, Cavani Francesco, Casiraghi Miriam, Grunebaum Eyal, Roifman Chaim M, Cervi Maria C, Ambrosi Alessandro, Carlucci Filippo, Roncarolo Maria Grazia, Villa Anna, Rubinacci Alessandro, Aiuti Alessandro

Клиническое исследование I фазыКлиническое исследование II фазыСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Adenosine deaminase (ADA) deficiency is a disorder of the purine metabolism leading to combined immunodeficiency and systemic alterations, including skeletal abnormalities. We report that ADA deficiency in mice causes a specific bone phenotype characterized by alterations of structural properties and impaired mechanical competence. These alterations are the combined result of an imbalanced receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin axis, causing decreased osteoclastogenesis and an intrinsic defect of osteoblast function with subsequent low bone formation. In vitro, osteoblasts lacking ADA displayed an altered transcriptional profile and growth reduction. Furthermore, the bone marrow microenvironment of ADA-deficient mice showed a reduced capacity to support in vitro and in vivo hematopoiesis. Treatment of ADA-deficient neonatal mice with enzyme replacement therapy, bone marrow transplantation, or gene therapy resulted in full recovery of the altered bone parameters. Remarkably, untreated ADA-severe combined immunodeficiency patients showed a similar imbalance in RANKL/osteoprotegerin levels alongside severe growth retardation. Gene therapy with ADA-transduced hematopoietic stem cells increased serum RANKL levels and children's growth. Our results indicate that the ADA metabolism represents a crucial modulatory factor of bone cell activities and remodeling.

Для цитирования: Sauer Aisha V, Mrak Emanuela, Hernandez Raisa Jofra, Zacchi Elena, Cavani Francesco, Casiraghi Miriam, Grunebaum Eyal, Roifman Chaim M, Cervi Maria C, Ambrosi Alessandro, Carlucci Filippo, Roncarolo Maria Grazia, Villa Anna, Rubinacci Alessandro, Aiuti Alessandro. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency.. Blood. 2009. DOI: 10.1182/blood-2009-03-209221.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.